VC firms sell Nu3 to trade

Apotheke financed the acquisition with the issuance of 54,470 new shares (valued at approximately €2.75m based on current share price) and an additional cash payment.

The vendors included Berlin- and Zurich-based VC firms Project A Ventures and Lakestar, as well as private investors including Alternative Strategic Investments.

Apotheke said Nu3's product range will complement its own and create additional cross-selling opportunities.

Nu3's founders will become shareholders in Apotheke together with Nu3 shareholder Jahr-Group.

Previous funding
Project A led a seed round for Nu3 in March 2012 and was joined by TA Venture in January 2013. Lakestar led the series-A in April 2013 at an undisclosed valuation, and Black River Ventures structured another round of growth funding in July 2014. The company has also raised venture debt from Davidson Technology.

Company
Established in 2011, Nu3 offers health, beauty and sports products, nutritional advice over the phone and a blog with technical advice and tips. The company is headquartered in Berlin, Germany. It generated revenues of €30m in 2017 and employs 154 people, according to publicly available documents.

People
Shop Apotheke Europe – Michael Köhler (CEO).
Nu3 – Robert Sünderhauf (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• DACH
• Consumer
• Germany
• Trade sale